Article Details

Alterity Therapeutics Limited (NASDAQ: ATHE): Why Investors Shouldn't Ditch ATHE Stock In 2021

Retrieved on: 2021-08-04 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

Alterity Therapeutics Limited (NASDAQ: ATHE): Why Investors Shouldn't Ditch ATHE Stock In 2021. View article details on hiswai:

Excerpt

Renaissance Technologies, LLC holds the second largest percentage of outstanding shares, with 0.56% or 0.22 million shares worth $0.32 million as ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up